Rajender R Aparasu

Summary

Affiliation: University of Houston
Country: USA

Publications

  1. Bali V, Chatterjee S, Carnahan R, Chen H, Johnson M, Aparasu R. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors. Psychiatr Serv. 2015;66:1333-40 pubmed publisher
    ..Future studies are needed to evaluate the impact of paroxetine on other cognition measures. ..
  2. Kamble P, Chen H, Johnson M, Bhatara V, Aparasu R. Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid. Psychiatr Serv. 2015;66:404-10 pubmed publisher
    ..Approved and nonapproved indications of second-generation antipsychotics influenced concurrent use in pediatric ADHD. ..
  3. Yucel A, Essien E, Sanyal S, Mgbere O, Aparasu R, Bhatara V, et al. Racial/ethnic differences in the treatment of adolescent major depressive disorders (MDD) across healthcare providers participating in the medicaid program. J Affect Disord. 2018;235:155-161 pubmed publisher
    ..For adolescents with MDD, being first diagnosed by a psychiatrist was associated with higher treatment rate and reduced racial/ethnic variation in the utilization of pharmacotherapy. ..
  4. request reprint
    Bali V, Kamble P, Aparasu R. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder. J Manag Care Spec Pharm. 2015;21:486-98 pubmed
    ..Concomitant use of atypical antipsychotics was associated with improved LAS treatment persistence in children and adolescents with ADHD. ..
  5. request reprint
    Bali V, Kamble P, Aparasu R. Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD. J Atten Disord. 2015;: pubmed
    ..19; 95% confidence interval = [0.60, 2.53]) when compared with users of LAS monotherapy. Concomitant use of LAS and AAP was not associated with risk of CVD events in ADHD patients when compared with LAS monotherapy. ..
  6. Chekani F, Bali V, Aparasu R. Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study. Res Social Adm Pharm. 2016;12:604-13 pubmed publisher
    ..Knowledge of these factors can be helpful in improving quality of life of patients with neurodegenerative diseases. ..
  7. Kachru N, Carnahan R, Johnson M, Aparasu R. Potentially inappropriate anticholinergic medication use in older adults with dementia. J Am Pharm Assoc (2003). 2015;55:603-612 pubmed publisher
    ..Given the adverse cognitive effects of these medications, there is a strong need to monitor and optimize their use in older adult patients with dementia. ..
  8. Bali V, Johnson M, Chen H, Fleming M, Holmes H, Aparasu R. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016;50:96-105 pubmed publisher
    ..Further studies are needed to evaluate the long-term cognitive effects of second-generation antidepressants in this vulnerable population. ..
  9. Chatterjee S, Bali V, Carnahan R, Johnson M, Chen H, Aparasu R. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression. Am J Geriatr Psychiatry. 2016;24:485-95 pubmed publisher
    ..With increasing safety concerns, there is a significant need to optimize anticholinergic use, especially for those who are at risk for dementia. ..

More Information

Publications14

  1. Aparasu R, Chatterjee S, Chen H. Antipsychotic Use and Risk of Nursing Home Admission Among Dual-Eligible Medicare Beneficiaries: A Propensity-Matched Study. Drugs Real World Outcomes. 2015;2:61-71 pubmed
    ..Given the safety concerns with atypical antipsychotics and their extensive use in the elderly, there is a need to be cautious while prescribing antipsychotics in the vulnerable elderly population. ..
  2. request reprint
    Bali V, Chatterjee S, Johnson M, Chen H, Carnahan R, Aparasu R. Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression. Am J Alzheimers Dis Other Demen. 2016;31:678-686 pubmed
    ..02, 95% CI: -0.16 to 0.21]) when compared to other SSRIs. There was no differential effect of paroxetine on cognition when compared to other SSRIs. ..
  3. Colavecchia A, Putney D, Johnson M, Aparasu R. Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017;13:857-863 pubmed publisher
    ..A significant association was found between computerized MRCI and 30-day HF readmission. Such predictive tools may allow pharmacists to prioritize patient care and optimize patient outcomes through medication therapy management. ..
  4. Chatterjee S, Bali V, Carnahan R, Chen H, Johnson M, Aparasu R. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression. Drugs Aging. 2017;34:691-700 pubmed publisher
    ..With increasing safety concerns, there is a significant need to optimize anticholinergic use in the vulnerable population. ..
  5. Rege S, Sura S, Aparasu R. Atypical antipsychotic prescribing in elderly patients with depression. Res Social Adm Pharm. 2018;14:645-652 pubmed publisher
    ..Less than 4% of the elderly visits with depression were prescribed atypical antipsychotics. Both clinical and demographic factors contribute to antipsychotic prescribing in elderly patients with depression. ..